Search



Search only items with full text availability
Current filters:

Clear current filters  or Add more filters

View Option



Results 1-10 of 174 (Search time: 0.002 seconds).

  Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia (Journal article)

  Increased platelet reactivity to the aggregatory effect of platelet activating factor, in vitro, in patients with heterozygous familial hypercholesterolaemia (Journal article)

  The influence of serum apolipoprotein e concentration and polymorphism on serum lipid parameters in hemodialysis patients (Journal article)

  Evaluation of alternative calculation methods for determining low-density lipoprotein cholesterol in hemodialysis patients (Journal article)

  The influence of serum apolipoprotein E concentration and polymorphism on serum lipid parameters in hemodialysis patients (Journal article)

  Erythropoietin administration in patients with chronic renal failure prevents the decrease in RBC-associated antioxidant enzyme activities (Journal article)

  Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patients (Journal article)

  Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure (Journal article)

  Epoetin alpha increases plasma HDL levels and HDL-associated PAF-acetylhydrolase activity in patients with chronic renal failure (Journal article)

  Erythrocyte PAF-acetylhydrolase activity in various stages of chronic kidney disease: Effect of long-term therapy with erythropoietin (Journal article)